CEO Steve Silvestro appointed to OptimizeRx Board effective June 20, 2025

OptimizeRx Corp

Board increased to six members and appointed CEO Stephen Silvestro as director.
Silvestro has served as CEO since March 2025, previously interim CEO from January 2025.
Appointment effective through the 2026 annual meeting; no financial impact disclosed.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Stephen Silvestro

director

OPRX · OptimizeRx Corp

Effective: 2025-06-20
Filed: Jun 24, 2025 23:59 UTC

appointed the Company’s CEO Stephen Silvestro to serve as a director

Source: SEC EDGAR

accession 0001213900-25-056908

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.